Technical University of Munich, Germany
Gene therapy restores fatty aldehyde dehydrogenase in Sjogren-Larsson syndrome
Published in Mental Health Business Week, August 26th, 2006
According to a report from Germany, "Sjogren-Larsson syndrome (SLS) is an autosomal recessive neurocutaneous disorder caused by mutation in the ALDH3A2 gene that codes for human fatty aldehyde dehydrogenase (FALDH). Sjogren-Larsson syndrome patients lack FALDH, which catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acids. The impaired FALDH activity leads to congenital ichthyosis, mental retardation, and spasticity. The current lack of treatment is an impetus to develop gene therapy strategies by introducing functional FALDH into defective cells."
"We...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Biogen Idec
Biogen Idec reports loss of $0.50 per share - NeuroMetrix
NeuroMetrix reports revenues of $14 million for second quarter, up 73 percent from previous year - Transitional Genomics Research Institute, U.S.
TGen/SARRC Research receives $7.1 million in state appropriations funding for autism research - Amarin
Amarin completes target patient enrollment in phase III trial of Miraxion in Huntington disease - American Medical Association
Tsunami survivors experiencing elevated rates of mental health problems - BrainStorm Cell Therapeutics
BrainStorm Cell Therapeutics retains investor relations firm - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
